Regulatory Affairs and Pharmacovigilance in Egypt: A Practical Guide for Pharma Companies
Egypt is an important pharmaceutical market in the Middle East and Africa, but market access requires more than completing an initial product registration. Companies must manage regulatory submissions, product information, labeling, safety surveillance, variations, and ongoing compliance throughout the medicine’s lifecycle.
The Egyptian Drug Authority (EDA) is responsible for regulating the quality, efficacy, and safety of pharmaceutical products and medical devices in Egypt. Its regulatory framework continues to evolve, with new guidance issued in areas such as bioequivalence, variations, pharmacovigilance, reliance, labeling, and product tracking.
**For more info visit to our site:**
https://www.ddregpharma.com/global-reach/regulatory-services-in-egypt
https://www.ddregpharma.com/global-reach/pharmacovigilance-services-in-egypt
It is NOT ok to contact this poster with other commercial interests.
Call seller